Immuron (IMRN) EBITDA Margin (2016 - 2024)
Immuron (IMRN) posted EBITDA Margin of 118.32% for Q3 2024, up 99.22% on a QoQ basis from 15150.57% in Q4 2023.
Powered by 
Analysis
Immuron (IMRN) EBITDA Margin (2016 - 2024) Analysis & Trends
Immuron has reported EBITDA Margin for 9 years, with the latest figure at 118.32% in Q3 2024.
- On a quarterly basis, EBITDA Margin changed N/A year-over-year to 118.32% in Q3 2024; TTM through Sep 2024 was 1039.03%, a N/A change from a year earlier, with the FY2026 full-year figure at 51.98%, up 2188.0% from the prior year.
- EBITDA Margin was 118.32% for Q3 2024 at Immuron, up from 15150.57% in the prior quarter.
- The five-year high for EBITDA Margin was 60.43% in Q4 2022, with the low at 28249.35% in Q4 2020.
- Average EBITDA Margin over 5 years is 7643.62%, with a median of 1141.52% recorded in 2021.
- The sharpest annual moves came in 2020 and 2021: EBITDA Margin sank 2815176 bps in 2020, then soared 2746114 bps in 2021.
- Over 5 years, EBITDA Margin stood at 28249.35% in 2020, then jumped by 97 bps to 788.22% in 2021, then jumped by 92 bps to 60.43% in 2022, then sank by 24972 bps to 15150.57% in 2023, then surged by 99 bps to 118.32% in 2024.
- The last three EBITDA Margin figures came in at 118.32% (Q3 2024), 15150.57% (Q4 2023), and 1494.83% (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 30.15% |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -562.07% |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 32.54% |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -25,380.93% |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 9, 2024 | -118.32% |
| Dec 31, 2023 | -15,150.57% |
| Jun 30, 2023 | -1,494.83% |
| Dec 31, 2022 | -60.43% |
| Dec 31, 2021 | -788.22% |
| Dec 31, 2020 | -28,249.35% |
| Dec 31, 2019 | -97.59% |
| Dec 31, 2018 | -161.98% |
| Dec 31, 2017 | 535.24% |
| Dec 31, 2016 | 481.82% |
| Jun 30, 2016 | 501.82% |
API Access
Immuron EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();